PHVS
Pharvaris N.V.
NASDAQ · Healthcare · Biotechnology · NL
$35.25
−1.15%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.08x
- Price / sales
- —
- Price / cash flow
- -13.65x
Enterprise value
- Enterprise value
- $2.1B
- EV / sales
- —
- EV / EBITDA
- -10.52x
- EV / EBIT
- -9.89x
- Market cap
- $2.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026